Vaccine design and delivery approaches for COVID-19
Review
[키워드] ACE2, Angiotensin Converting Enzyme 2, Coalition for Epidemic Preparedness Innovations
Ad, Adenovirus
APC, Antigen-Presenting Cell
approach
ASHP, American Society of Health-System Pharmacists
CDC, Centers for Disease Control and Prevention
Chimpanzee Adenoviral Vector 1, ChAdOx1
COVID-19
COVID-19, Coronavirus Disease-19
described
disease
dissemination
effective
Effective vaccines
EUA, Emergency Use Authorization
GMV, Genetically Modified Viruses
humans
I.M., Intramuscular
knowledge
LAV, Live-Attenuated Virus
LMH, Live Modified Horsepox
LNP, Lipid Nanoparticles
MERS, Middle East respiratory syndrome
MVA, Modified Vaccinia Ankara
New
PAMP, Pathogen-Associated Molecular Pattern
producing
PRR, Pattern Recognition Receptors
RBD, receptor binding domain
RSV, respiratory syncytial virus
S.C., Subcutaneous
SAGE, Strategic Advisory Group of Experts on Immunization
SARS-CoV-2
SARS-COV-2, severe acute respiratory syndrome coronavirus-2
Side effect
the disease
TLR, Toll-like receptor
vaccination
Vaccine
vaccine delivery
Vaccine design
VEE, Venezuelan Equine Encephalitis
VLP, virus-like particle
VRP, Virion Replicon Particle
WCA, Whole-Cell Antigen
[DOI] 10.1016/j.intimp.2021.108086 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2021.108086 PMC 바로가기 [Article Type] Review